Trials / Recruiting
RecruitingNCT06376981
Hyaluronic Acid in Shoulder Tendinopathy
Benefit of a Subacromial Injection Combining Corticosteroid and Hyaluronic Acid Versus Corticosteroid Alone in Supraspinatus Tendinopathy
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 132 (estimated)
- Sponsor
- Centre Hospitalier Departemental Vendee · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Multicentric, randomised study to compare the effectiveness on activity pain at 3 months of corticosteroid injection associated with hyaluronic acid with corticosteroids injection alone in patients with tendinopathy of the supraspinatus with clinical reevaluation at one, three and six months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyaluronic acid injection | An injection of 2 ml of Acid hyaluronic |
| DRUG | Corticosteroid injection | An injection of 1 ml of corticosteroids |
| DRUG | Placebo injection | An injection of 2 ml of placebo (physiological serum) |
Timeline
- Start date
- 2024-09-19
- Primary completion
- 2026-12-19
- Completion
- 2027-03-19
- First posted
- 2024-04-22
- Last updated
- 2024-10-03
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06376981. Inclusion in this directory is not an endorsement.